Use of a bisphosphonate in the preparation of a medicament for the treatmentof osteoporosis post hip fracture to prevent or reduce subsequent osteoporoticskeletal fractures in a patient in need of such treatment, and particularly toa patient who has undergone recent repair of the hip fracture andcorresponding methods of treatment.